CONFERENCE PROCEEDINGS
Advanced Search
Home > Proceedings > Volume 12828 > Article
Presentation + Paper
12 March 2024 Interstitial photodynamic therapy for malignant gliomas: the Munich experience
Maximilian Aumiller, Stefanie Quach, Marco Foglar, Mohamed El Fahim, Adrian Rühm, Herbert Stepp, Robert Forbrig, Niklas Thon, Ronald Sroka
Author Affiliations +
Proceedings Volume 12828, Neural Imaging and Sensing 2024; 1282805 (2024) https://doi.org/10.1117/12.3002942
Event: SPIE BiOS, 2024, San Francisco, California, United States
Abstract
5-aminolevulinic acid (5-ALA) mediated interstitial photodynamic therapy (iPDT) is undergoing clinical trials for the treatment of malignant gliomas. 5-ALA iPDT is based on the creation of reactive oxygen species (ROS) via excitation of 5-ALA mediated protoporphyrin IX (PpIX) in the tumor cells and causing a phototoxic reaction. After iPDT local chemo-radiation is performed as adjuvant therapy. 16 newly diagnosed glioblastomas and 44 malignant glioma recurrences treated with 5-ALA iPDT in Munich were retrospectively analyzed for treatment outcome, spectral online monitoring and changes in the MRI. iPDT for newly diagnosed glioblastomas showed a median overall survival (OS) of 28 months, 16.4 months progression free survival (PFS), respectively. 43.8% patients with newly diagnosed glioblastoma experienced a long term PFS > 24 months. In addition, the methylation of the MGMT promotor showed to be a prognostic factor for prolonged survival (p=0.04). In case of recurrent malignant gliomas PFS after iPDT was 7.1 months with 25% >24 months survival after iPDT (17.9% PFS > 24 months). Analysis of spectral online monitoring showed that a measured decrease of the laser light transmission between the cylindrical diffuser fibers, used for the irradiation, can be associated with silent hemorrhages visible in terms of T1-hyperintensity in the MRI after iPDT. Overall 5-ALA iPDT is a promising tool for the treatment of glioblastomas and other malignant gliomas with prolonged survival and minimally invasive surgery.
Conference Presentation
(2024) Published by SPIE. Downloading of the abstract is permitted for personal use only.
Citation Download Citation
Maximilian Aumiller, Stefanie Quach, Marco Foglar, Mohamed El Fahim, Adrian Rühm, Herbert Stepp, Robert Forbrig, Niklas Thon, and Ronald Sroka "Interstitial photodynamic therapy for malignant gliomas: the Munich experience", Proc. SPIE 12828, Neural Imaging and Sensing 2024, 1282805 (12 March 2024); https://doi.org/10.1117/12.3002942
ACCESS THE FULL ARTICLE
ORGANIZATIONAL
Sign in with credentials provided by your organization.
INSTITUTIONAL
Select your institution to access the SPIE Digital Library.
SELECT YOUR INSTITUTION
PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
PERSONAL SIGN IN
No SPIE Account? Create one
PURCHASE THIS CONTENT
SUBSCRIBE TO DIGITAL LIBRARY
50 downloads per 1-year subscription
Members: $195
Non-members: $335 ADD TO CART
25 downloads per 1 - year subscription
Members: $145
Non-members: $250 ADD TO CART
PURCHASE SINGLE ARTICLE
Includes PDF, HTML & Video, when available
Members: $17.00
Non-members: $21.00 ADD TO CART
PROCEEDINGS
 2 PAGES + PRESENTATION
DOWNLOAD PAPER SAVE TO MY LIBRARY
WATCH
PRESENTATION
GET CITATION
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Tumors
Photodynamic therapy
Magnetic resonance imaging
Brain
Surgery
Visible radiation
RELATED CONTENT
Subscribe to Digital Library
Receive Erratum Email Alert
Back to Top